摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

acetic acid 4,4-diethoxy-1,1-dimethyl-2-oxo-butyl ester | 463335-45-7

中文名称
——
中文别名
——
英文名称
acetic acid 4,4-diethoxy-1,1-dimethyl-2-oxo-butyl ester
英文别名
Acetic acid 4,4-diethoxy-1,1-dimethyl-2-oxobutyl ester;(5,5-diethoxy-2-methyl-3-oxopentan-2-yl) acetate
acetic acid 4,4-diethoxy-1,1-dimethyl-2-oxo-butyl ester化学式
CAS
463335-45-7
化学式
C12H22O5
mdl
——
分子量
246.304
InChiKey
FJLNSJDWBNDVER-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    312.5±32.0 °C(Predicted)
  • 密度:
    1.024±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    17
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    61.8
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Efficient Synthesis of a GABAA α2,3-Selective Allosteric Modulator via a Sequential Pd-Catalyzed Cross-Coupling Approach
    摘要:
    A practical synthesis of 2- [3-(4-fluoro-3-pyridin-3-yl-phenyl)-imidazo [1,2-a] pyrimidin-7-yl] -propan-2-ol (1), an oral GABA(A) alpha(2/3)-selective agonist, is described. The five-step process, which afforded 1 in 40% overall yield, included imidazopyrimidine 2 and pyridine boronic acid 4 as key fragments. The synthesis is highlighted by consecutive Pd-catalyzed coupling steps to assemble the final free base 1 in high yield and regioselectivity. A novel method for Pd removal in the final step is also described.
    DOI:
    10.1021/jo050741o
  • 作为产物:
    参考文献:
    名称:
    Efficient Synthesis of a GABAA α2,3-Selective Allosteric Modulator via a Sequential Pd-Catalyzed Cross-Coupling Approach
    摘要:
    A practical synthesis of 2- [3-(4-fluoro-3-pyridin-3-yl-phenyl)-imidazo [1,2-a] pyrimidin-7-yl] -propan-2-ol (1), an oral GABA(A) alpha(2/3)-selective agonist, is described. The five-step process, which afforded 1 in 40% overall yield, included imidazopyrimidine 2 and pyridine boronic acid 4 as key fragments. The synthesis is highlighted by consecutive Pd-catalyzed coupling steps to assemble the final free base 1 in high yield and regioselectivity. A novel method for Pd removal in the final step is also described.
    DOI:
    10.1021/jo050741o
点击查看最新优质反应信息

文献信息

  • [EN] IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS<br/>[FR] DERIVES D'IMIDAZO-PYRIMIDINE UTILISES COMME LIGANDS POUR LES RECEPTEURS GABA
    申请人:MERCK SHARP & DOHME
    公开号:WO2002074772A1
    公开(公告)日:2002-09-26
    A class of 3-phenylimidazo[1,2-a]pyrimidine derivatives, substituted at the meta position of the phenyl ring by a directly attached, optionally halo- and/or cyano-substituted aryl or heteroaryl group, and further substituted on the phenyl ring by one or two fluorine atoms, are selective ligands for GABAA receptors, in particular having good affinity for the α2 and/or α3 and/or α5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
    一类3-苯基咪唑[1,2-a]嘧啶衍生物,取代苯环的间位,直接连接一个可选择的卤素和/或氰基取代的芳基或杂环基团,并在苯环上进一步取代一个或两个氟原子,是选择性的GABAA受体配体,特别是对其α2和/或α3和/或α5亚单位具有良好的亲和力,因此对于治疗和/或预防中枢神经系统的不良症状,包括焦虑、惊厥和认知障碍具有益处。
  • [EN] IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS<br/>[FR] DERIVES D'IMIDAZO-PYRIMIDINE COMME LIGANDS POUR LES RECEPTEURS GABA
    申请人:MERCK SHARP & DOHME
    公开号:WO2002074773A1
    公开(公告)日:2002-09-26
    A class of 3-phenylimidazo[1,2-a]pyrimidine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a -NH- linkage, and further substituted on the phenyl ring by alkyl, trifluoromethyl, alkoxy or one or two halogen atoms, especially fluoro, are selective ligands for GABAA receptors, in particular having good affinity for the a2 and/or a3 and/or a5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
    一类3-苯基咪唑并[1,2-a]嘧啶衍生物,苯环的间位被取代为可选择取代的芳基或杂环基,该基团直接连接或通过氧原子或-NH-键桥接,并且苯环上进一步取代为烷基,三氟甲基,烷氧基或一个或两个卤素原子,特别是氟原子。这些化合物是GABAA受体的选择性配体,特别是对其中的a2和/或a3和/或a5亚基具有良好的亲和力,因此有助于治疗和/或预防中枢神经系统的不良症状,包括焦虑,抽搐和认知障碍。
  • Imidazo-pyrimidine derivatives as ligands for gaba receptors
    申请人:——
    公开号:US20020193385A1
    公开(公告)日:2002-12-19
    A class of 3-phenylimidazo[1,2-&agr;]pyrimidine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, and further substituted on the phenyl ring by alkyl, trifluoromethyl, alkoxy or one or two halogen atoms, especially fluoro, are selective ligands for GABA A receptors, in particular having good affinity for the &agr;2 and/or &agr;3 and/or &agr;5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
    一类3-苯基咪唑[1,2-&agr;]嘧啶衍生物,苯环的间位被取代,取代基可以是直接连接或通过氧原子或-NH-键桥接的取代芳基或杂环芳基,苯环上进一步被取代为烷基,三氟甲基,烷氧基或一个或两个卤素原子,特别是氟,是GABAA受体的选择性配体,特别是对其中的&agr;2和/或&agr;3和/或&agr;5亚基具有良好的亲和力,因此对于治疗和/或预防中枢神经系统的不良症状,包括焦虑,惊厥和认知障碍具有益处。
  • Imidazo-pyrimidine derivatives as ligands for GABA receptors
    申请人:Merck Sharp & Dohme Ltd.
    公开号:US07030128B2
    公开(公告)日:2006-04-18
    A class of imidazo[1,2-α]pyrimidine derivatives, substituted at the 3-position by an optionally substituted five-membered or six-membered heteroaromatic ring, are selective ligands for GABAA receptors, in particular having good affinity for the α2 and/or α3 and/or α5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
    一类在3位取代了一个选择性取代的五元或六元杂环芳香环的咪唑[1,2-α]嘧啶衍生物是GABAA受体的选择性配体,尤其对其中的α2和/或α3和/或α5亚基具有良好的亲和力,因此对于治疗和/或预防中枢神经系统的不良症状,包括焦虑、抽搐和认知障碍具有益处。
  • Imidazo[1,2<i>-a</i>]pyrimidines as Functionally Selective and Orally Bioavailable GABA<sub>A</sub>α2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders
    作者:Simon C. Goodacre、Leslie J. Street、David J. Hallett、James M. Crawforth、Sarah Kelly、Andrew P. Owens、Wesley P. Blackaby、Richard T. Lewis、Joanna Stanley、Alison J. Smith、Pushpinder Ferris、Bindi Sohal、Susan M. Cook、Andrew Pike、Nicola Brown、Keith A. Wafford、George Marshall、José L. Castro、John R. Atack
    DOI:10.1021/jm051065l
    日期:2006.1.1
    A series of high-affinity GABA(A) agonists with good oral bioavailability in rat and dog and functional selectivity for or the GABA(A)alpha 2 and -alpha 3 subtypes is reported. The 7-trifluoroinethylimidazopyrimidine 14g and the 7-propan-2-olimidazopyrimidine 14k are anxiolytic in both conditioned and unconditioned animal models of anxiety with minimal sedation observed at full BZ binding site occupancy.
查看更多